                               SEQUENCE LISTING

<110> EIGER BIOPHARMACEUTICALS, INC.

<110> ERASMUS MC

<120> TREATMENT OF HEPATITIS E VIRUS INFECTION WITH INTERFERON LAMBDA

<130> 106707-1286907 (003810PC)

<150> 63/119,524
<151> 2020-11-30

<150> 63/149,788
<151> 2021-02-16

<160> 3     

<170> PatentIn version 3.5

<210> 1
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 1
gctgaaggac tgcaggtgcc a                                                 21


<210> 2
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 2
gggctggtcc aagacgtcca  	                                                20

<210> 3
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 3
gctgaaggac tgcaagtgcc g                                                 21
